Fora Capital, LLC Exact Sciences Corp Transaction History

Fora Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$59.06 - $75.72 $1.59 Million - $2.04 Million	-26,962 Reduced 80.08%	6,708 $496,000
Q3 2023 Nov 13, 2023	BUY	$65.94 - $99.04 $1.76 Million - $2.64 Million	26,679 Added 381.62%	33,670 $2.3 Million
Q2 2023 Aug 11, 2023	BUY	$62.68 - $95.05 $438,195 - $664,494	6,991 New	6,991 $656,000
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $270,626 - $417,917	8,465 New	8,465 $275,000
Q1 2021 May 17, 2021	SELL	$116.57 - $155.01 $58,168 - $77,349	-499 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$99.61 - $142.12 $49,705 - $70,917	499 New	499 $66,000

661

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.92B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.